Sonida Senior Living Debt to Equity Ratio 2012-2025 | SNDA
Current and historical debt to equity ratio values for Sonida Senior Living (SNDA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Sonida Senior Living debt/equity for the three months ending September 30, 2025 was 18.87.
| Sonida Senior Living Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $0.82B | $0.04B | 23.31 |
| 2025-06-30 | $0.79B | $0.06B | 12.59 |
| 2025-03-31 | $0.76B | $0.07B | 11.74 |
| 2024-12-31 | $0.76B | $0.08B | 9.74 |
| 2024-09-30 | $0.71B | $0.09B | 8.40 |
| 2024-06-30 | $0.69B | $-0.03B | -20.12 |
| 2024-03-31 | $0.68B | $-0.04B | -16.37 |
| 2023-12-31 | $0.74B | $-0.12B | -6.40 |
| 2023-09-30 | $0.73B | $-0.10B | -7.06 |
| 2023-06-30 | $0.73B | $-0.09B | -8.08 |
| 2023-03-31 | $0.73B | $-0.08B | -9.33 |
| 2022-12-31 | $0.76B | $-0.10B | -7.50 |
| 2022-09-30 | $0.76B | $-0.09B | -8.96 |
| 2022-06-30 | $0.76B | $-0.07B | -10.95 |
| 2022-03-31 | $0.77B | $-0.06B | -12.20 |
| 2021-12-31 | $0.78B | $-0.05B | -16.56 |
| 2021-09-30 | $0.83B | $-0.15B | -5.39 |
| 2021-06-30 | $0.87B | $-0.19B | -4.56 |
| 2021-03-31 | $0.93B | $-0.24B | -3.86 |
| 2020-12-31 | $0.98B | $-0.28B | -3.52 |
| 2020-09-30 | $1.00B | $-0.26B | -3.86 |
| 2020-06-30 | $1.01B | $-0.04B | -22.68 |
| 2020-03-31 | $1.01B | $-0.03B | -31.39 |
| 2019-12-31 | $1.25B | $0.01B | 87.16 |
| 2019-09-30 | $1.29B | $0.00B | 402.18 |
| 2019-06-30 | $1.31B | $0.02B | 56.63 |
| 2019-03-31 | $1.31B | $0.03B | 38.59 |
| 2018-12-31 | $1.11B | $0.04B | 31.59 |
| 2018-09-30 | $1.08B | $0.06B | 18.08 |
| 2018-06-30 | $1.09B | $0.07B | 15.79 |
| 2018-03-31 | $1.09B | $0.08B | 14.43 |
| 2017-12-31 | $1.10B | $0.08B | 13.70 |
| 2017-09-30 | $1.09B | $0.09B | 12.79 |
| 2017-06-30 | $1.10B | $0.09B | 12.04 |
| 2017-03-31 | $1.09B | $0.10B | 11.28 |
| 2016-12-31 | $1.03B | $0.12B | 8.80 |
| 2016-09-30 | $0.99B | $0.12B | 7.99 |
| 2016-06-30 | $0.94B | $0.13B | 7.38 |
| 2016-03-31 | $0.92B | $0.13B | 7.11 |
| 2015-12-31 | $0.88B | $0.14B | 6.51 |
| 2015-09-30 | $0.82B | $0.14B | 5.87 |
| 2015-06-30 | $0.79B | $0.14B | 5.86 |
| 2015-03-31 | $0.77B | $0.14B | 5.64 |
| 2014-12-31 | $0.75B | $0.14B | 5.31 |
| 2014-09-30 | $0.74B | $0.14B | 5.13 |
| 2014-06-30 | $0.69B | $0.15B | 4.70 |
| 2014-03-31 | $0.59B | $0.16B | 3.81 |
| 2013-12-31 | $0.59B | $0.16B | 3.72 |
| 2013-09-30 | $0.50B | $0.16B | 3.17 |
| 2013-06-30 | $0.49B | $0.17B | 2.89 |
| 2013-03-31 | $0.46B | $0.17B | 2.75 |
| 2012-12-31 | $0.47B | $0.17B | 2.78 |
| 2012-09-30 | $0.39B | $0.17B | 2.31 |
| 2012-06-30 | $0.39B | $0.17B | 2.29 |
| 2012-03-31 | $0.34B | $0.17B | 1.98 |
| 2011-12-31 | $0.29B | $0.17B | 1.73 |
| 2011-09-30 | $0.27B | $0.17B | 1.60 |
| 2011-06-30 | $0.23B | $0.17B | 1.39 |
| 2011-03-31 | $0.21B | $0.17B | 1.29 |
| 2010-12-31 | $0.22B | $0.16B | 1.34 |
| 2010-09-30 | $0.22B | $0.16B | 1.38 |
| 2010-06-30 | $0.22B | $0.16B | 1.37 |
| 2010-03-31 | $0.22B | $0.16B | 1.37 |
| 2009-12-31 | $0.22B | $0.16B | 1.41 |
| 2009-09-30 | $0.23B | $0.16B | 1.43 |
| 2009-06-30 | $0.23B | $0.16B | 1.46 |
| 2009-03-31 | $0.23B | $0.16B | 1.46 |
| 2008-12-31 | $0.23B | $0.16B | 1.50 |
| 2008-09-30 | $0.24B | $0.16B | 1.51 |
| 2008-06-30 | $0.24B | $0.15B | 1.54 |
| 2008-03-31 | $0.24B | $0.15B | 1.55 |
| 2007-12-31 | $0.24B | $0.15B | 1.60 |
| 2007-09-30 | $0.24B | $0.15B | 1.63 |
| 2007-06-30 | $0.25B | $0.15B | 1.67 |
| 2007-03-31 | $0.24B | $0.15B | 1.67 |
| 2006-12-31 | $0.25B | $0.14B | 1.74 |
| 2006-09-30 | $0.25B | $0.14B | 1.77 |
| 2006-06-30 | $0.25B | $0.14B | 1.79 |
| 2006-03-31 | $0.28B | $0.15B | 1.94 |
| 2005-12-31 | $0.29B | $0.15B | 1.99 |
| 2005-09-30 | $0.29B | $0.15B | 1.97 |
| 2005-06-30 | $0.28B | $0.15B | 1.92 |
| 2005-03-31 | $0.28B | $0.15B | 1.88 |
| 2004-12-31 | $0.28B | $0.15B | 1.88 |
| 2004-09-30 | $0.28B | $0.15B | 1.86 |
| 2004-06-30 | $0.28B | $0.15B | 1.81 |
| 2004-03-31 | $0.28B | $0.15B | 1.83 |
| 2003-12-31 | $0.30B | $0.12B | 2.39 |
| 2003-09-30 | $0.26B | $0.12B | 2.10 |
| 2003-06-30 | $0.15B | $0.12B | 1.22 |
| 2003-03-31 | $0.16B | $0.12B | 1.30 |
| 2002-12-31 | $0.16B | $0.12B | 1.35 |
| 2002-09-30 | $0.16B | $0.12B | 1.39 |
| 2002-06-30 | $0.17B | $0.12B | 1.42 |
| 2002-03-31 | $0.19B | $0.12B | 1.66 |
| 2001-12-31 | $0.20B | $0.11B | 1.71 |
| 2001-09-30 | $0.20B | $0.11B | 1.75 |
| 2001-06-30 | $0.21B | $0.11B | 1.84 |
| 2001-03-31 | $0.20B | $0.11B | 1.83 |
| 2000-12-31 | $0.21B | $0.11B | 1.88 |
| 2000-09-30 | $0.21B | $0.11B | 1.86 |
| 2000-06-30 | $0.11B | $0.11B | 1.01 |
| 2000-03-31 | $0.11B | $0.11B | 1.00 |
| 1999-12-31 | $0.11B | $0.11B | 1.03 |
| 1999-09-30 | $0.11B | $0.12B | 0.93 |
| 1999-06-30 | $0.10B | $0.11B | 0.88 |
| 1999-03-31 | $0.10B | $0.11B | 0.93 |
| 1998-12-31 | $0.10B | $0.11B | 0.96 |
| 1998-09-30 | $0.06B | $0.10B | 0.63 |
| 1998-06-30 | $0.03B | $0.10B | 0.29 |
| 1998-03-31 | $0.03B | $0.09B | 0.28 |
| 1997-12-31 | $0.01B | $0.09B | 0.08 |
| 1997-09-30 | $0.08B | 0.00 | |
| 1997-06-30 | $0.00B | 0.00 | |
| 1997-03-31 | $0.00B | 0.00 | |
| 1996-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.594B | $0.304B |
| Sonida Senior Living is an owner-operator of senior living communities and services. Sonida Senior Living, formerly known as Capital Senior Living Corporation, is based in DALLAS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $168.076B | 30.86 |
| HCA Healthcare (HCA) | United States | $109.268B | 18.09 |
| CVS Health (CVS) | United States | $100.704B | 11.58 |
| Elevance Health (ELV) | United States | $82.860B | 12.15 |
| Cencora (COR) | United States | $67.884B | 21.88 |
| Natera (NTRA) | United States | $33.085B | 0.00 |
| DiDi Global (DIDIY) | China | $23.203B | 21.43 |
| Labcorp Holdings (LH) | United States | $21.720B | 16.56 |
| Medpace Holdings (MEDP) | United States | $17.364B | 43.11 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.188B | 0.00 |
| Viatris (VTRS) | United States | $15.146B | 5.64 |
| ICON (ICLR) | Ireland | $14.921B | 14.81 |
| BioMerieux (BMXMF) | France | $14.304B | 0.00 |
| Solventum (SOLV) | United States | $13.884B | 13.48 |
| Revvity (RVTY) | United States | $12.644B | 23.28 |
| CochLear (CHEOY) | Australia | $11.671B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.650B | 20.51 |
| Avantor (AVTR) | United States | $8.441B | 12.90 |
| Sonic Healthcare (SKHHY) | Australia | $7.636B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.454B | 0.00 |
| HealthEquity (HQY) | United States | $7.313B | 27.35 |
| BrightSpring Health Services (BTSG) | United States | $6.935B | 41.34 |
| PACS (PACS) | United States | $6.185B | 37.61 |
| Bausch + Lomb (BLCO) | Canada | $6.135B | 40.28 |
| Sotera Health (SHC) | United States | $5.452B | 26.29 |
| Alignment Healthcare (ALHC) | United States | $4.351B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.022B | 53.08 |
| Concentras Parent (CON) | United States | $2.619B | 16.34 |
| Progyny (PGNY) | United States | $2.252B | 44.27 |
| Organon (OGN) | United States | $2.238B | 2.36 |
| Surgery Partners (SGRY) | United States | $1.993B | 25.68 |
| Establishment Labs Holdings (ESTA) | United States | $1.923B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.891B | 11.29 |
| Ardent Health (ARDT) | United States | $1.244B | 4.06 |
| Nutex Health (NUTX) | United States | $1.173B | 8.97 |
| Teladoc Health (TDOC) | United States | $1.173B | 0.00 |
| CareDx (CDNA) | United States | $1.045B | 17.08 |
| GoodRx Holdings (GDRX) | United States | $0.933B | 15.28 |
| Omada Health (OMDA) | United States | $0.898B | 0.00 |
| Embecta (EMBC) | United States | $0.755B | 4.29 |
| InnovAge Holding (INNV) | United States | $0.752B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.733B | 0.00 |
| Enhabit (EHAB) | United States | $0.547B | 24.55 |
| CryoPort (CYRX) | United States | $0.545B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.481B | 0.00 |
| SBC Medicals (SBC) | United States | $0.456B | 8.40 |
| Agilon Health (AGL) | United States | $0.402B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.52 |
| Oncology Institute (TOI) | United States | $0.330B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.279B | 0.00 |
| So-Young (SY) | China | $0.272B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.255B | 53.65 |
| KindlyMD (NAKA) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.196B | 0.00 |
| LifeMD (LFMD) | United States | $0.185B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.143B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.137B | 0.00 |
| DocGo (DCGO) | United States | $0.087B | 0.00 |
| Biodesix (BDSX) | United States | $0.068B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.067B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| Pomdoctor - (POM) | China | $0.031B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.28 |
| Intelligent Bio Solutions (INBS) | United States | $0.019B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.015B | 0.00 |
| Lifeward (LFWD) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |